Screening Protocol for Preliminary Eligibility Determination for Adoptive Cell Therapy Trials
NCT05100316
·
clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
16
Enrollment
INDUSTRY
Sponsor class
Stopped
Trial terminated due to feasibility reasons
Conditions
Neoplasms
Interventions
OTHER:
Screening Platform
Sponsor
GlaxoSmithKline